| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AMERICAN RENAL ASSOCIATES Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BECTON DICKINSON | 151,55 | -0,92 % | ROUNDUP: Becton, Dickinson Boosts FY26 Adj. EPS Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 42,670 | +0,04 % | Should Investors Buy Boston Scientific Stock Despite Near-Term Risks? | ||
| ALIGN TECHNOLOGY | 146,95 | -2,20 % | Align Technology To Add Three Directors And Raise 2026 Share Repurchases To Up To $500 Million | ||
| BAXTER | 23,600 | -0,92 % | Why Baxter International Stock Skyrocketed by 19% This Week | ||
| ATOSSA THERAPEUTICS | 2,020 | -1,94 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| ELEVANCE HEALTH | 340,60 | -0,12 % | Elevance Health Raises FY26 Guidance; Expects To Return To At Least 12% Adj. EPS Growth In 2027 | WASHINGTON (dpa-AFX) - Elevance Health (ELV) said second quarter results exceeded its outlook. The company increased 2026 EPS guidance to at least $20.10, and lifted 2026 adjusted EPS guidance... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 30,800 | -1,28 % | AMN Healthcare Services, Inc.: Amn Healthcare Announces Second Quarter 2026 Results | Quarterly revenue of $673 million and adjusted EBITDA of $73 million;
GAAP income of $0.53/share and adjusted EPS of $0.77
DALLAS, Aug. 6, 2026 /PRNewswire/ --... ► Artikel lesen | |
| ADDUS HOMECARE | 102,00 | 0,00 % | Addus outlines full-year adjusted EBITDA margin of 12%-13% while pursuing larger acquisitions | ||
| AXOGEN | 38,760 | -3,41 % | Axogen, Inc. Reports Second Quarter 2026 Financial Results | ALACHUA, Fla. and TAMPA, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,650 | -0,60 % | SINTX Technologies, Inc.: SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program | SALT LAKE CITY, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced biomaterials and silicon nitride technologies for medical... ► Artikel lesen | |
| ALPHATEC | 7,700 | -4,35 % | Alphatec signals $140M adjusted EBITDA guidance for 2026 while maintaining ~$882M revenue outlook | ||
| AVANOS MEDICAL | 21,600 | 0,00 % | AVANOS MEDICAL, INC. - 15-12G, Securities registration termination | ||
| OPTION CARE HEALTH | 21,000 | +1,94 % | Option Care Health, Inc.: Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026 | BANNOCKBURN, Ill., July 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate... ► Artikel lesen | |
| ATRICURE | 33,000 | -8,33 % | Director At AtriCure Sells $134K Of Stock | ||
| APYX MEDICAL | 3,480 | -1,14 % | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece... ► Artikel lesen |